APYX:NASDAQ, Apyx Medical Corporation

APYX stock overview

Apyx Medical Corporation (APYX:NASDAQ) closed at $2.57 on October 14, 2026, down 1.15% on the day. The stock trades 49.4% below its 52-week high of $5.08 and 10.8% above its 52-week low of $2.32. Over the past year, it lost 17.4%. Apyx Medical Corporation is part of the Health Care sector (Medical/Dental Instruments).

Key figures

Price
$2.57
Day change
-1.15%
Volume
38,747
Average volume
129,557
Market cap
108M+
52-week range
$2.32 – $5.08
50-day average
$2.97
200-day average
$3.67

Performance

5D 1M 3M 6M 1Y
-3.02% -13.18% -39.95% -34.77% -17.36%

Price action over the past year

In 252 trading sessions since October 14, 2025, APYX closed higher on 112 days (44%). Its best day was May 7, 2026 (+21.92%) and its worst was September 28, 2026 (-15.54%). The stock moved 10% or more in a single session 13 times.

Recent signals

APYX news

About Apyx Medical Corporation

Apyx Medical Corp, formerly Bovie Medical Corp is an energy-based medical device company. It specializes in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company's medical devices are marketed under its own brands, Bovie, IDS, ICON and DERMTM and on a private label basis to distributors throughout the world. Bovie also leverages its expertise in the design, development, and manufacturing of electrosurgical equipment by producing equipment for large, well-known medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for its energy based designs.

Similar stocks

Find more stocks like APYX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.